<?xml version="1.0" encoding="UTF-8"?>
<p>For a subset of the individuals, blood samples were collected in serum separator and EDTA (ethylenediaminetetraacetic acid) tubes for serum and plasma, respectively. Stool and urine samples were also collected from the laboratory-confirmed positive cases. Since SARS-CoV-2 is a new virus and diagnostic tests are evolving rapidly, it was considered critical to have various types of clinical samples for standardization and validation of new tests. However, owing to very low positivity rates of SARS-CoV-2 infection, it was subsequently decided to collect blood samples from only laboratory-confirmed positive cases and review the strategy later.</p>
